Enzi Leads GOP HELP Committee Inquiry Into Alleged NEA Political Activity
Wednesday, September 23, 2009
WASHINGTON, D.C. – U.S. Sen. Mike Enzi (R-Wyo.), Ranking Member of the Senate’s Health, Education, Labor and Pensions (HELP) Committee, today led his fellow Republican HELP Committee members in requesting an explanation regarding possible violations of federal law at the National Endowment for the Arts (NEA). Enzi and his colleagues sent the request to NEA Chairman Rocco Landesman.
In the letter delivered today the Senators questioned the possibility of “taxpayer dollars to engage in lobbying activities to promote the President’s health care legislative agenda and other legislative priorities” during several August conference calls with NEA grant recipients and community stakeholders.The letter also raises serious questions regarding how the NEA’s participation in these calls may have violated federal criminal restrictions on lobbying Congress, the Hatch Act, appropriations restrictions on spending funds for such purposes and possible contradictions with the entity’s mission under its authorizing statute.
“…The promotion to NEA grant recipients of topics that are at the top of the President’s legislative agenda and urging a call to action creates a serious conflict of interest,” wrote the Senators.
###
Recent News
- Harkin Statement on House Vote That Would Make College More Expensive for Millions of American Students [Chairman]
- Harkin Reintroduces FIT Kids Act to Combat Childhood Obesity and Promote Physical Activity [Chairman]
- Alexander Opposes Nominees to NLRB Who Remained on Board After Court Found Their Appointments Unconstitutional [Ranking Member]
- Senate Health Committee Passes Alexander and Colleagues’ Bill to Fix Responsibility for Safety of Sterile Compounded Drugs [Ranking Member]
- Harkin Statement on HELP Committee Approval of a Full Slate of Five Nominees to the NLRB [Chairman]
- Harkin Statement on HELP Committee Passage of the Pharmaceutical Compounding Quality and Accountability Act and the Drug Supply Chain Security Act [Chairman]
